atai Life Sciences announces the launch of PsyProtix, to develop a precision psychiatry approach for Treatment-Resistant Depression (TRD) - Yahoo Finance

Submitted by Anonymous (not verified) on Mon, 10/11/2021 - 12:00

atai Life Sciences announces the launch of PsyProtix, to develop a precision psychiatry approach for Treatment-Resistant Depression (TRD)  Yahoo Finance